Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib for Brain Metastases in HER2-Positive Breast Cancer
jRCT2080220279Phase 2
- Sponsor
- GSK
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lapatinib in breast cancer and brain metastases, sponsored by GSK.
02
Drugs
lapatinib
03
Conditions
breast cancerbrain metastases
Beyond the preview
Go deeper on jRCT2080220279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220279.